Oligomerix Announces Series B Extension Raise Of $2.7 Million To Support Phase 1 Clinical Development
Round Type
Series B
White PlainsHealthcareDescription
Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, announced that the Company has recently closed an extension of its Series B funding round, raising $2.7 million. Funding from the Series B will allow Oligomerix to accelerate its transition into Phase 1 human clinical development planned for early 3Q 2022.
Quick answer
Oligomerix raised an undisclosed amount in a Series B round, dated June 2, 2022. Oligomerix is based in White Plains, New York, United States.
- How much did Oligomerix raise?
- Oligomerix raised an undisclosed amount in a Series B round on June 2, 2022.
- What does Oligomerix do?
- Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare tauopathies such as progressive..
- Where is Oligomerix based and how big is it?
- Oligomerix is based in White Plains, New York, United States.
- Who are the decision-makers at Oligomerix?
- Fundz holds 1 contact at Oligomerix, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Oligomerix that raised within 45 days of this round, from Fundz verified event records.
- SciLogica raised $1M (Seed) on July 15, 2022.
- THUNDER ROAD SURGICAL raised $5.8M on July 15, 2022.
- InHomeTherapy, Inc. raised $12M on July 15, 2022.
- Renibus Therapeutics raised $15M on July 15, 2022.
- Andarta Medical, Inc. raised an undisclosed amount (Series B) on July 14, 2022.
- Greenbrook TMS raised $16M on July 14, 2022.
Who to call at Oligomerix, and when
A new round usually means Oligomerix is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Oligomerix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oligomerix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oligomerix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oligomerix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansOligomerix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.